The MHRA is considering a policy of mutual recognition of devices by 2025

The UK Medicines and Healthcare products Regulatory Agency is considering introducing a policy of mutual recognition of medical devices that have marketing authorization in four other jurisdictions, including the US and the EU. While there are important exceptions – such as for certain items qualifying as software as a medical device – these rules will come into force at some point in 2025, making it easier to develop products in a market with almost 67 million potential patients.

BioWorld MedTech Regulatory Europe MHRA